Matrixyl (Palmitoyl Pentapeptide-4)

Matrixyl (Palmitoyl Pentapeptide-4, also designated Pal-KTTKS or palmitoyl-Lys-Thr-Thr-Lys-Ser) is a lipopeptide consisting of the pentapeptide KTTKS (a sequence derived from the procollagen type I C-propeptide) with an N-terminal palmitoyl (C16 fatty acid) chain covalently attached. Developed by Sederma and published by Robinson et al. (International Journal of Cosmetic Science, 2005), Matrixyl represents a mechanistically distinct approach to extracellular matrix biology research using peptide-lipid conjugates.

The KTTKS sequence (Lys-Thr-Thr-Lys-Ser) corresponds to residues 147-151 of the human procollagen type I C-propeptide — a region that functions as a cell-signalling domain promoting fibroblast proliferation and extracellular matrix synthesis. In isolation, the KTTKS pentapeptide is active but has limited cell permeability and metabolic stability. The palmitoyl modification addresses both limitations: the C16 fatty acid chain enables association with lipid bilayers, improving cellular uptake and interaction with membrane-proximal signalling proteins, while also providing steric protection of the peptide N-terminus against aminopeptidase degradation.

Fibroblast biology research with Matrixyl examines: procollagen type I synthesis (by ELISA measuring carboxy-terminal propeptide, PICP); fibronectin expression; and glycosaminoglycan production (using dimethylmethylene blue colorimetric assay). Cell migration research uses scratch assay and transwell migration paradigms. Matrix remodelling research examines MMP-1 (collagenase) and TIMP-1 expression as indicators of collagen turnover balance.

Comparison with GHK-Cu in parallel fibroblast assays is a productive research design: both compounds stimulate collagen synthesis but through distinct mechanisms — Matrixyl through procollagen-derived signalling sequences, GHK-Cu through copper coordination chemistry and SP1 transcriptional activation. Identifying synergistic versus additive versus antagonistic interactions between these two approaches characterises the independence of their collagen-stimulating mechanisms.

MW: 802.08 g/mol (with palmitoyl chain). CAS: 214047-00-4. Limited aqueous solubility due to palmitoyl chain — prepare stocks in DMSO or ethanol (10mM), dilute in aqueous media maintaining less than 1% organic solvent. Store lyophilised at -20°C. For laboratory and analytical research purposes only.

Matrixyl in comparative collagen synthesis research: a well-designed comparison experiment uses Matrixyl, GHK-Cu, ascorbic acid (vitamin C, the enzymatic cofactor for prolyl and lysyl hydroxylase in collagen crosslinking), and TGF-beta1 (the primary fibroblast collagen synthesis-stimulating growth factor) as four parallel treatment groups at their respective EC50 concentrations. Measuring procollagen type I C-propeptide (PICP by ELISA), type I collagen protein (SDS-PAGE + densitometry), and COL1A1/COL1A2 mRNA (RT-PCR) across all four conditions simultaneously characterises the mechanistic landscape of fibroblast collagen stimulation. Matrixyl's procollagen-derived signalling sequence mechanism operates through a different receptor/pathway than TGF-beta1's Smad2/3 signalling — synergy between Matrixyl and TGF-beta1 at sub-maximal concentrations would confirm mechanistic independence.

The palmitoyl chain requires awareness during storage and handling: lipopeptides are more susceptible to hydrolysis at the ester-like amide bond connecting the fatty acid to the peptide than standard peptides, particularly at elevated pH and temperature. Store Matrixyl strictly at -20°C, avoid alkaline reconstitution conditions, and prepare working solutions fresh. Reconstitute in DMSO or ethanol at 10mM stock, dilute in aqueous media at less than 1% organic solvent. MW: 802.08 g/mol. CAS: 214047-00-4. For laboratory and analytical research purposes only.

Matrixyl research in 3D tissue models: two-dimensional fibroblast monolayer culture does not fully recapitulate the three-dimensional ECM environment in which collagen synthesis and remodelling biology occurs in vivo. For more physiologically relevant Matrixyl research, use fibroblast-populated collagen lattice (FPCL) or dermal equivalent models. Seed human dermal fibroblasts (1×10^5 cells/mL) in neutralised type I collagen solution (2mg/mL) in 24-well plates. Allow gelation at 37°C for 30 minutes, then overlay with culture medium containing Matrixyl (1nM-10µM) or vehicle. After 7 days, measure lattice contraction (a measure of fibroblast contractile activity and collagen remodelling) by photographing plates and calculating lattice area versus initial area. Harvest lattices for hydroxyproline assay (total collagen content), qRT-PCR (COL1A1, COL1A2, MMP-1 expression), and histology (Masson's trichrome staining for collagen fibre organisation). Three-dimensional culture endpoints provide collagen synthesis data that is more predictive of in vivo biology than 2D assays. MW: 802.08 g/mol. CAS: 214047-00-4. Prepare stocks in DMSO or ethanol. Store lyophilised at -20°C. For laboratory and analytical research purposes only.